| Lorlatinib in a Child with ALK-Fusion–Positive High-Grade Glioma A Bagchi, BA Orr, O Campagne, S Dhanda, S Nair, Q Tran, ... New England Journal of Medicine 385 (8), 761-763, 2021 | 39 | 2021 |
| KRAS insertion mutations are oncogenic and exhibit distinct functional properties Y White, A Bagchi, J Van Ziffle, A Inguva, G Bollag, C Zhang, H Carias, ... Nature communications 7 (1), 10647, 2016 | 20 | 2016 |
| High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experience J Chiang, A Bagchi, X Li, SK Dhanda, J Huang, SN Pinto, E Sioson, ... Neuro-oncology 26 (1), 178-190, 2024 | 12 | 2024 |
| Molecular classification improves therapeutic options for infants and young children with medulloblastoma A Bagchi, SK Dhanda, P Dunphy, E Sioson, GW Robinson Journal of the National Comprehensive Cancer Network 21 (10), 1097-1105, 2023 | 11 | 2023 |
| Impact of preanalytical factors on the measurement of tumor tissue biomarkers using immunohistochemistry A Bagchi, Z Madaj, KB Engel, P Guan, DC Rohrer, DR Valley, E Wolfrum, ... Journal of Histochemistry & Cytochemistry 69 (5), 297-320, 2021 | 11 | 2021 |
| Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy M Zuckermann, C He, J Andrews, A Bagchi, R Sloan-Henry, B Bianski, ... Molecular cancer 23 (1), 123, 2024 | 2 | 2024 |
| LGG-53. RESULTS FROM THE PHASE 1 AND PHASE 1 EXPANSION COHORTS OF SJ901: A PHASE 1/2 TRIAL OF SINGLE-AGENT MIRDAMETINIB (PD-0325901) IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS … GW Robinson, A Vinitsky, AK Bag, J Chiang, QI Li, T Lin, ME Hoehn, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | 1 | 2024 |
| Efficacy and safety of entrectinib in children with extracranial solid or primary central nervous system (CNS) tumors harboring NTRK or ROS1 fusions AV Desai, GW Robinson, Y Wu, H Wang, EM Basu, A Bagchi, ... Journal of Clinical Oncology 42 (16_suppl), 10000-10000, 2024 | 1 | 2024 |
| QOL-24. NEUROLOGIC AND NEUROCOGNITIVE OUTCOMES AMONG SURVIVORS OF INFANT-TYPE HEMISPHERIC GLIOMA (IHG) A Bagchi, E Hanzlik, J Chiang, S Lensing, M Bryndziar, J Ashford, A Singh, ... Neuro-Oncology 26 (Supplement_8), viii267-viii268, 2024 | | 2024 |
| TRLS-12. EFFICACY AND SAFETY OF ENTRECTINIB IN CHILDREN WITHNTRK ORROS1 FUSION-POSITIVE (FP) PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS A Bagchi, GW Robinson, AV Desai, Y Wu, H Wang, EM Basu, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| OTHR-12. GENERATING A COMPREHENSIVE INTERACTIVE PEDIATRIC BRAIN TUMOR VISUALIZATION PORTAL FROM MOLECULAR AND CLINICAL DATA DERIVED FROM TWO MULTI-INSTITUTIONAL PROTOCOLS … SK Dhanda, C Lu, E Sioson, APY Liu, SA Upadhyaya, A Bagchi, J Chiang, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| HGG-13. INFANT-TYPE HEMISPHERIC GLIOMA (IHG): AN INDIVIDUAL PATIENT DATA META-ANALYSIS L Chavaz, A Bagchi, F Toutain, SM Pfister, D Sturm, T Pietsch, GH Gielen, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| HGG-03. HIGH-GRADE GLIOMA IN YOUNG CHILDREN IS HISTOLOGICALLY, MOLECULARLY, AND CLINICALLY DIVERSE—RESULTS FROM THE SJYC07 TRIAL AND INSTITUTIONAL EXPERIENCE J Chiang, A Bagchi, X Li, SK Dhanda, J Huang, SN Pinto, E Sioson, ... Neuro-Oncology 25 (Supplement_1), i38-i39, 2023 | | 2023 |
| Neuro-Oncology Practice K Abdullah, DC Adamson, H Ahmad, C Amidei, O Andronesi, A Bagchi, ... | | 2023 |
| Rare cases of medulloblastoma with hypermutation A Bagchi, I Beddows, A Cornelius, GW Robinson, SD Jewell Cancer Reports 5 (5), e1521, 2022 | | 2022 |
| Neuro-Oncology Practice M Abdelbaki, DC Adamson, C Amidei, CK Anders, F Andreiuolo, EK Avila, ... | | 2022 |
| Molecular Characteristics of Primary and Recurrent Medulloblastoma: Potential Insights to Alternative Therapy A Bagchi Van Andel Research Institute, 2019 | | 2019 |
| MUTATIONAL SIGNATURES AND IMMUNOPHENOTYPE IN RECURRENT MEDULLOBLASTOMA: AN INDICATION FOR NOVEL THERAPEUTIC APPROACH A Bagchi, M Bowman, G Hostetter, S Jewell PEDIATRIC BLOOD & CANCER 65, 2018 | | 2018 |
| TARGETING AUTOPHAGY IN MYC AMPLIFIED MEDULLOBLASTOMA A Bagchi, J MacKeigan, A Cornelius PEDIATRIC BLOOD & CANCER 63, S70-S70, 2016 | | 2016 |
| Biochemical and Functional Analysis of Novel KRAS Insertions in MPN and Other Cancers YN White, A Bagchi, J Van Ziffle, G Bollag, C Zhang, DS Dickens, ML Loh, ... Blood, The Journal of the American Society of Hematology 124 (21), 2207-2207, 2014 | | 2014 |
Sandeep Kumar DhandaSt. Jude Children's Research Hospital在 stjude.org 的电子邮件经过验证
